Saturday, 22 June 2024
  
Login

Australia's most trusted
source of pharma news

Saturday, 22 June 2024
Listen to this story 
News

Companies unveil new drug plans

Posted 7 June 2024 AM

Three companies have begun the process to gain government subsidy for their cancer drugs ahead of TGA approval, an update from the Medical Services Advisory Committee (MSAC) shows.

Certain tests to determine eligibility for Taiho Pharma's Lytgobi, A Menarini's Orserdu, and Roche's inavolisib on the PBS have been scheduled for MSAC's PICO Advisory Sub Committee's (PASC) meeting in August 2024.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (29)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (7)

Other (20)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.